Categories: News

Cloud DX Initiates Trading on the OTCQB

WATERLOO, ON / ACCESSWIRE / July 14, 2021 / Cloud DX (TSXV:CDX), (OTCQB:CDXFF), a leading Canadian-based, North American provider of virtual care and remote patient monitoring solutions is pleased to announce that on July 14, 2021 the Company’s shares will begin trading on the OTCQB Venture Market under the symbol “CDXFF”. The Company’s shares also continue to trade on the Toronto Venture Stock Exchange (TSVX) under the symbol “CDX”.

“This represents a new milestone for Cloud DX as we execute on our growth strategy and mission to make healthcare better for everyone,” says Company CEO, Robert Kaul. The US market is not only an important market for us in terms of investor interest, but is also the focus of future growth for the business, with the virtual care opportunity representing a total addressable market of $250 Billion USD. Listing on a US exchange will help Cloud DX increase its exposure to a broader investor audience and elevate our stature with US healthcare payers and providers and the patients they serve.”

The OTCQB is a leading market for early stage and developing companies and is operated by the OTC Markets Group Inc. To be eligible for approval to trade on the OTCQB companies must be current on disclosure obligations, provide an annual company verification and management certification process, and pass a minimum bid price test. The OTCQB quality standards create a solid baseline of transparency, and offer the technology to improve the information and trading experience for investors. It also provides access for investors who cannot access trading on the TSX Venture Exchange.

About Cloud DX

Accelerating virtual healthcare’s future, Cloud DX is making healthcare better for everyone. The company’s Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company ‘World Changing Idea’ finalist and one of ‘Canada’s Ten Most Prominent Telehealth Providers.’

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

# # #

Social Links

Twitter: https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries please contact:

Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

SOURCE: Cloud DX Inc.

View source version on accesswire.com:
https://www.accesswire.com/655489/Cloud-DX-Initiates-Trading-on-the-OTCQB

Staff

Recent Posts

Fortitude Wellbeing Enhances Mental Health Services with Comprehensive ADHD Assessments

Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…

37 minutes ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

2 hours ago

Mexico’s EHR Revolution: Driving Digital Health Innovation and Market Growth, Insights From Black Book Research

Key Trends, Vendor Performance, and Opportunities Transforming Mexico's Healthcare IT Landscape MIAMI, FLORIDA / ACCESSWIRE…

2 hours ago

Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees

Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or…

5 hours ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…

5 hours ago

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused…

5 hours ago